UPDATED May 20, 2024
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LION | RON2.77 | 0.7% | 13.5% | RON1.4b | n/a | PE3.2x | n/a | 4.7% | Diversified Financials | ||
EVER | RON1.28 | -2.7% | -2.7% | RON1.2b | n/a | PE5.9x | n/a | 7.1% | Diversified Financials | ||
TRANSI | RON0.34 | 2.7% | 10.1% | RON741.2m | n/a | PE3.2x | n/a | 4.4% | Diversified Financials | ||
ATB | RON2.00 | 5.0% | 222.8% | RON1.3b | n/a | PE13.9x | n/a | 2.3% | Pharmaceuticals & Biotech | ||
CMVX | RON108.00 | 2.9% | n/a | RON1.2b | n/a | PE6.6x | n/a | 9.9% | Transportation | ||
BIO | RON0.79 | -3.4% | 19.5% | RON776.5m | n/a | PE11.7x | n/a | 3.9% | Pharmaceuticals & Biotech | ||
SOCP | RON1.67 | -4.8% | 88.7% | RON1.1b | n/a | PE10.7x | n/a | 4.3% | Transportation | ||
SCD | RON3.30 | 3.8% | 63.4% | RON2.2b | n/a | PE10.3x | n/a | 0% | Pharmaceuticals & Biotech | ||
TTS | RON24.35 | -6.3% | 79.0% | RON1.5b | RON30.40 | PE6.4x | E-22.7% | 4.7% | Transportation | ||
TGN | RON21.20 | 9.6% | 17.6% | RON4.1b | RON21.26 | PE13.2x | E21.8% | 1.7% | Utilities | ||
BVB | RON64.50 | 0.6% | 40.2% | RON521.0m | RON31.00 | PE20.1x | S-18.4% | 2.4% | Diversified Financials | ||
SFG | RON36.20 | 4.9% | 110.5% | RON1.4b | RON31.73 | PE16.2x | E2.7% | 2.9% | Consumer Services |